0001192482-15-000020.txt : 20150205 0001192482-15-000020.hdr.sgml : 20150205 20150205165801 ACCESSION NUMBER: 0001192482-15-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150204 FILED AS OF DATE: 20150205 DATE AS OF CHANGE: 20150205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spark Therapeutics, Inc. CENTRAL INDEX KEY: 0001609351 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462654405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 888-772-7560 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Children's Hospital of Philadelphia Foundation CENTRAL INDEX KEY: 0001632060 STATE OF INCORPORATION: PA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36819 FILM NUMBER: 15580878 BUSINESS ADDRESS: STREET 1: 34TH STREET AND CIVIC CENTER BOULEVARD CITY: PHILADELPHIA STATE: PA ZIP: 19004 BUSINESS PHONE: 267-426-6957 MAIL ADDRESS: STREET 1: 34TH STREET AND CIVIC CENTER BOULEVARD CITY: PHILADELPHIA STATE: PA ZIP: 19004 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-02-04 0001609351 Spark Therapeutics, Inc. ONCE 0001632060 Children's Hospital of Philadelphia Foundation 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 0 0 1 0 Common Stock 2015-02-04 4 C 0 1000000 A 5943629 D Common Stock 2015-02-04 4 C 0 2795031 A 8738660 D Common Stock 2015-02-04 4 C 0 61552 A 8800212 D Common Stock 2015-02-04 4 P 0 100000 23.00 A 8900212 D Series A Preferred Stock 2015-02-04 4 C 0 1000000 0 D Common Stock 1000000 0 D Series B Preferred Stock 2015-02-04 4 C 0 2795031 0 D Common Stock 2795031 0 D Accrued Preferred Stock Dividends 2015-02-04 4 C 0 61552 0 D Common Stock 61552 0 D Shares of Series A Preferred Stock automatically converted into shares of the Common Stock on a one-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering on February 4, 2015. Shares of Series B Preferred Stock automatically converted into shares of the Common Stock on a one-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering on February 4, 2015. Paid-in-kind dividends declared and paid on the Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock on a one-for-one basis without payment of further consideration upon the closing of the issuer's initial public offering on February 4, 2015. Jeffrey D. Kahn, Attorney-In-Fact for The Children's Hospital of Philadelphia Foundation 2015-02-04